MedPath

The effects of Omega 3 fatty acid supplements on treatment of type 2 diabetes complications

Not Applicable
Conditions
Diabetes type 2.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2015061922769N3
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

diabetics men and women aged 30-65 years old, ; BMI in the range of 35-25 BMI ranged 25-35; the desire to maintain weight during the study weight maintenance tendency during the study; the tendency to maintain normal activities during the current life style tendency to keep current life style and activities during the study; willingness to cooperate in the project
Exclusion criteria: changing on the dose or types of diabetes medications; inflammatory disease given; unwillingness to continue the cooperation; taking ten percent supplement non using ten or more percent of the supplements; any allergic reactions to omega-3 components

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Irisin. Timepoint: The beginning and end of the study (before and after intervention). Method of measurement: ELISA.;Myonectin. Timepoint: The beginning and end of the study (before and after intervention). Method of measurement: ELISA.;BDNF(Brain Derived Neurotrophic Factor). Timepoint: The beginning and end of the study (before and after intervention). Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath